Ameriprise’s Oracle ORCL Stock Holding History

Ameriprise’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.01M	Buy	+13,700	New	+$2.48M	﹤0.01%	3077
2025 Q4	–	Sell	-5,200	Closed	-$1.46M	–	4178
2025 Q3	$1.46M	Buy	+5,200	New	+$1.32M	﹤0.01%	3169

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameriprise's ORCL Position: Q2 2026 in Review

Ameriprise reduced its Oracle (ORCL) stake by 3.2% in Q2 2026, selling an estimated $39.1M and leaving 6,447,514 shares worth $946M. The position accounts for 0.19% of the portfolio, ranked #113.

Ameriprise first reported a position in ORCL in Q2 2013 and has held it in 53 quarters since. The position peaked at $2B in Q3 2025. 3,524 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

Ameriprise held 6,447,514 shares of Oracle worth $946M as of Q2 2026.
Ameriprise sold 216,013 Oracle shares in Q2 2026, an estimated $39.1M.
Oracle made up 0.19% of Ameriprise's portfolio in Q2 2026, its #113 holding.
Ameriprise first reported a position in Oracle in Q2 2013 and has held it in 53 quarters since.
Ameriprise's Oracle position peaked at $2B in Q3 2025.
3,524 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.